About Shreya Life Sciences Private Limited
Data last updated:
Shreya Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1991PTC061136. Its GSTIN is 27AADCS9890C3ZZ (Maharashtra). The company holds 18 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6.8 Cr. It was formerly known as Amika Trading Pvt Ltd. It is led by directors Sujit Kumar Singh (Managing Director) and Himanshu Baldev Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shreya House 6th Floor 301/A Pereira Hill Road Andheri East, Mumbai, Maharashtra, India – 400099.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,946.23 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹17.43 Cr (net margin 0.6%) and EBITDA of ₹46.61 Cr (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 142% over three years and 68% over five years.
The company has about 1,169 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹507.9 Cr and satisfied charges of ₹961.83 Cr on record. Court records list 188 cases involving the company, including 74 filed by the company and 114 filed against it; 47 cases are pending. The company has 7 deals on record (5 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹20 Cr; the latest was in September 2025. Its 10 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Akums Drugs and Pharmaceuticals Limited with revenue of ₹4,170.28 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,897 overdue payments to 79 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreya.co.in.
Company details
Contact details
Shreya Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is shreya.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShreya House 6th Floor 301/A Pereira Hill Road Andheri East, Mumbai, Maharashtra, India – 400099
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shreya Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shreya Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shreya Life Sciences Private Limited, buy the company report.
Financials of Shreya Life Sciences Private Limited
FY 2025 filings availableShreya Life Sciences Private Limited reported revenue of ₹2,946.23 Cr (up 284% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 284% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2,946.23 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shreya Life Sciences Private Limited, buy the company report.
Board of directors of Shreya Life Sciences Private Limited
Shreya Life Sciences has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Baldev Singh | Whole-Time Director | 01 Jun 2018 | 8 Years 4 Months | Current |
| Sujit Kumar Singh | Managing Director | 30 Sep 1999 | 27 Years 1 Months | Current |
Peer comparison
Shreya Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Akums Drugs and Pharmaceuticals Limited | ₹4,170.28 Cr (FY 2025) | -1.0% | Delhi, India | |||
| J B Chemicals and Pharmaceuticals Limited | ₹3,956.31 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Glaxosmithkline Pharmaceuticals Limited | ₹3,895.14 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Cadila Pharmaceuticals Limited | ₹3,869.17 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Acg Associated Capsules Private Limited | ₹3,600.7 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Shreya Life Sciences Private Limitedthis company | ₹2,946.23 Cr (FY 2025) | ₹17.43 Cr | 0.6% | 284.0% | 1,169 | Mumbai, Maharashtra, India |
| Amneal Pharmaceuticals Private Limited | ₹2,944.87 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Eris Lifesciences Limited | ₹2,912 Cr (FY 2025) | 43.0% | Ahmedabad, Gujarat, India | |||
| Sandoz Private Limited | ₹2,778.2 Cr (FY 2025) | -2.0% | Navi Mumbai, Maharashtra, India | |||
| Biological E. Limited | ₹2,708 Cr (FY 2024) | -30.0% | Telangana, India | |||
| Pfizer Limited | ₹2,453.6 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Shreya Life Sciences Private Limited, buy the company report.
Auditor
Shreya Life Sciences Private Limited is audited by BRAHM & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BRAHM & ASSOCIATES | FY 2024 | 102153W |
Shareholding
The shareholding of Shreya Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shreya Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2025 | 101082476 | Others | ₹5.4 Cr | Open | |
| 29 Jun 2024 | 100939963 | Others | ₹4.5 Cr | Open | |
| 16 Aug 2013 | 10443051 | Open Joint Stock Company Promsvyazbank | ₹180 Cr | Open | |
| 11 Jan 2012 | 10329971 | Open Joint Stock Company Promsvyazbank | ₹318 Cr | Open | |
| 11 Mar 2024 | 100885250 | Indian Overseas Bank | ₹49.8 Lakh | Satisfied |
To see the full charge records of Shreya Life Sciences Private Limited, buy the company report.
Total charge records: 42 View all charges
Deals & funding
Shreya Life Sciences Private Limited has 7 deals on record (5 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹20 Cr; the latest was in September 2025.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Nov 2017 | Acquisition | ₹89.88 Cr | Buyer: Piramal Enterprises Ltd Seller: Shreya Life Sciences Private Limited |
| Jan 2017 | Secondary share transfer | Undisclosed | Buyer: RS Investments Private Limited Seller: Zee International Far East Limited |
| Feb 2013 | Funding round | ₹20 Cr | Investors: an individual |
| Apr 2011 | Secondary share transfer | Undisclosed | Buyer: Zee International Far East Limited Seller: RS Investments Private Limited |
To see the full deal history of Shreya Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Shreya Life Sciences Private Limited has 188 court cases on record: 74 filed by Shreya Life Sciences, 114 filed against it. 47 cases are pending and 141 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 113 | 70 | 28 |
| High courts | 63 | 41 | 16 |
| NCLAT | 8 | 0 | 3 |
| Supreme Court | 2 | 2 | 0 |
| NCLT | 2 | 1 | 0 |
Cases on record (5 of 188)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Rajkumar Offset Printers Pvt Ltd. | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Lic Housing Finance Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed against the company by Alembic Pharmaceuticals Ltd | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Alembic Pharmaceuticals Ltd | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed against the company by Walter Bushnell Private Limited and 2 Ors. and 2 others | Pending |
To see the full case history of Shreya Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Shreya Life Sciences Private Limited was last rated by Crisil on 08 Apr 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 08 Apr 2020 |
To see the full credit ratings and regulatory alerts of Shreya Life Sciences Private Limited, buy the company report.
MSME payment delays
Shreya Life Sciences Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,897 overdue payments to 79 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 79)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bla Packaging Industries Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Ganesh Metal Industries | |||
| Eks Filter Technik India Private Limited |
To see the full MSME payment records of Shreya Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Shreya Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Serena Pharma Private Limited | U24239MH2001PTC131489 |
To see the full group structure of Shreya Life Sciences Private Limited, buy the company report.
Employees & EPFO
Shreya Life Sciences Private Limited has a workforce of 1,169 employees on its EPFO records as of Mar 26, 2025, across 2 active EPFO establishments.
GST
Shreya Life Sciences has 18 GST registrations: 14 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCS9890C3ZZ | Maharashtra | Active | 20 May 2025 |
| 05AADCS9890C1Z7 | Uttarakhand | Active | 01 Jul 2017 |
| 06AADCS9890C1Z5 | Haryana | Active | 01 Jul 2017 |
| 07AADCS9890C1Z3 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shreya Life Sciences Private Limited, buy the company report.
Recent activity
Shreya Life Sciences Private Limited has 11 board changes on record since 1999: 2 appointments and 9 cessations. The latest: Bhavik Bhupendra Parekh ceased to be Company Secretary on 09 Dec 2019.
91 earlier events are in the company report.
Frequently asked questions
Shreya Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 1991 (35+ years old) and is registered under CIN U51900MH1991PTC061136.
Shreya Life Sciences has 2 current directors:
- Sujit Kumar Singh - Managing Director
- Himanshu Baldev Singh - Whole-Time Director
The latest financial statements of Shreya Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shreya Life Sciences is 27AADCS9890C3ZZ, registered in Maharashtra. The company has 18 GST registrations in all, of which 14 are active and 4 are cancelled or inactive. Other active GSTINs include 05AADCS9890C1Z7 (Uttarakhand), 06AADCS9890C1Z5 (Haryana), 07AADCS9890C1Z3 (Delhi).
The CIN (Corporate Identification Number) of Shreya Life Sciences is U51900MH1991PTC061136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreya Life Sciences has 188 court cases on record: 74 filed by the company and 114 filed against it. 47 are pending. Most are in the district courts.
Shreya Life Sciences was incorporated on 10 April 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.
Shreya Life Sciences has 7 deals on record (5 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹20 Cr; the latest was in September 2025.
The peers of Shreya Life Sciences by revenue are Akums Drugs and Pharmaceuticals Limited, J B Chemicals and Pharmaceuticals Limited, Glaxosmithkline Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Acg Associated Capsules Private Limited and 5 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhavik Bhupendra Parekh ceased to be Company Secretary on 09 Dec 2019. Sujit Kumar Singh ceased to be Director on 01 Apr 2019. Sheel Kumar Dhananjay Singh ceased to be Director on 10 Mar 2019. Shreya Life Sciences has 11 board changes on record in total.
Shreya Life Sciences has 13 MSME Form 1 returns on record between 2019 and 2023, listing 1,897 overdue payments to 79 micro and small suppliers. The latest return was filed on 09 Jan 2024.
Shreya Life Sciences can be reached through the website shreya.co.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
